Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Jones

Showing results (371-380 of 463) with videos related to

Pageof 47
Sort By:
Diabetes, Obesity & Metabolism|May 15, 2015
Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?D Russell-Jones, T Danne, K Hermansen, et al.
Journal of Computer Assisted Tomography|February 10, 2000
The identification of cerebral volume changes in treated growth hormone-deficient adults using serial 3D MR image processingE R Denton, M Holden, E Christ, et al.
BMJ (Clinical Research Ed.)|August 1, 1992
An infected prosthetic hip. Is there a role for prophylactic antibiotics?J C Mason, C T Dollery, A So, et al.
Diabetes Technology & Therapeutics|July 31, 2025
Continuous Glucose Monitoring Metrics and Continuous Glucose Monitoring-Based Hypoglycemia, Including Duration, in Individuals with Type 1 Diabetes Switching to Once-Weekly Insulin Icodec: A Post Hoc Evaluation of ONWARDS 6Thomas Danne, Susanne Engberg, Concetta Irace, et al.
Diabetes, Obesity & Metabolism|September 15, 2022
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetesAthena Philis-Tsimikas, Harpreet S Bajaj, Kamilla Begtrup, et al.
Clinical Endocrinology|July 1, 1997
Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathyP V Carroll, A M Umpleby, E Albany, et al.
Prehospital and Disaster Medicine|July 18, 2012
Evaluation of active mortality surveillance system data for monitoring hurricane-related deaths-Texas, 2008Ekta Choudhary, David F Zane, Crystal Beasley, et al.
Gut|April 16, 2005
Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegalyL A Thomas, M J Veysey, G M Murphy, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2013
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extensionChantal Mathieu, Priscilla Hollander, Bresta Miranda-Palma, et al.
JACC. Cardiovascular Interventions|July 26, 2014
Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine modelSaibal Kar, Dongming Hou, Russell Jones, et al.
Pageof 47

Showing results (371-380 of 463) with videos related to

Sort By:
Pageof 47
Diabetes, Obesity & Metabolism|May 15, 2015
Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake?D Russell-Jones, T Danne, K Hermansen, et al.
Journal of Computer Assisted Tomography|February 10, 2000
The identification of cerebral volume changes in treated growth hormone-deficient adults using serial 3D MR image processingE R Denton, M Holden, E Christ, et al.
BMJ (Clinical Research Ed.)|August 1, 1992
An infected prosthetic hip. Is there a role for prophylactic antibiotics?J C Mason, C T Dollery, A So, et al.
Diabetes Technology & Therapeutics|July 31, 2025
Continuous Glucose Monitoring Metrics and Continuous Glucose Monitoring-Based Hypoglycemia, Including Duration, in Individuals with Type 1 Diabetes Switching to Once-Weekly Insulin Icodec: A Post Hoc Evaluation of ONWARDS 6Thomas Danne, Susanne Engberg, Concetta Irace, et al.
Diabetes, Obesity & Metabolism|September 15, 2022
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetesAthena Philis-Tsimikas, Harpreet S Bajaj, Kamilla Begtrup, et al.
Clinical Endocrinology|July 1, 1997
Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathyP V Carroll, A M Umpleby, E Albany, et al.
Prehospital and Disaster Medicine|July 18, 2012
Evaluation of active mortality surveillance system data for monitoring hurricane-related deaths-Texas, 2008Ekta Choudhary, David F Zane, Crystal Beasley, et al.
Gut|April 16, 2005
Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegalyL A Thomas, M J Veysey, G M Murphy, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2013
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extensionChantal Mathieu, Priscilla Hollander, Bresta Miranda-Palma, et al.
JACC. Cardiovascular Interventions|July 26, 2014
Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine modelSaibal Kar, Dongming Hou, Russell Jones, et al.
Pageof 47